190 related articles for article (PubMed ID: 33793088)
1. Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non-small cell lung cancer: A propensity score matching analysis.
Sun Y; Zhang Q; Wang Z; Shao F
Thorac Cancer; 2021 May; 12(10):1589-1597. PubMed ID: 33793088
[TBL] [Abstract][Full Text] [Related]
2. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
Ma K; Wang TY; He BL; Chang D; Gong M
Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
[TBL] [Abstract][Full Text] [Related]
3. Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study.
Zhao Y; Mao Y; He J; Gao S; Zhang Z; Ding N; Xue Q; Gao Y; Wang D; Zhao J; Tan F; Yuan L; Li F; Wang S; Yang L
Clin Lung Cancer; 2021 Mar; 22(2):e201-e210. PubMed ID: 33187913
[TBL] [Abstract][Full Text] [Related]
4. Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.
Wang X; Yan S; Lv C; Wang Y; Wang J; Li S; Zhang L; Yang Y; Wu N
Clin Lung Cancer; 2017 Nov; 18(6):e411-e416. PubMed ID: 28576593
[TBL] [Abstract][Full Text] [Related]
5. The effect of the extent of lymph node dissection for stage IA non-small-cell lung cancer on patient disease-free survival.
Xu F; Qi L; Yue D; Wang C
Clin Lung Cancer; 2013 Mar; 14(2):181-7. PubMed ID: 23195117
[TBL] [Abstract][Full Text] [Related]
6. Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.
Adachi H; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Yamanaka K; Watanabe K; Kumakiri Y; Tsuboi M; Maehara T; Nakayama H; Masuda M
J Thorac Oncol; 2017 Jan; 12(1):85-93. PubMed ID: 27553515
[TBL] [Abstract][Full Text] [Related]
7. Station 3A lymph node dissection does not improve long-term survival in right-side operable non-small-cell lung cancer patients: A propensity score matching study.
Yang MZ; Tan ZH; Li JB; Long H; Fu JH; Zhang LJ; Lin P; Hou X; Yang HX
Thorac Cancer; 2022 Aug; 13(15):2106-2116. PubMed ID: 35702992
[TBL] [Abstract][Full Text] [Related]
8. Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage IA and pathological stage T1 non-small cell lung cancer.
Ma K; Chang D; He B; Gong M; Tian F; Hu X; Ji Z; Wang T
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1289-95. PubMed ID: 18504610
[TBL] [Abstract][Full Text] [Related]
9. Does the extent of lymph nodes dissection affect the prognosis of resected stage IA non-small cell lung cancer?
Xu F; Wang C; Qi L; Yu W; Li Q
Clin Transl Oncol; 2014 Jan; 16(1):77-84. PubMed ID: 23615980
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
Liu C; Wei S; Guo C; Mei J; Pu Q; Liu L
Ann Surg Oncol; 2021 Jan; 28(1):194-202. PubMed ID: 32638165
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
[TBL] [Abstract][Full Text] [Related]
12. The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.
Stiles BM; Kamel MK; Nasar A; Harrison S; Nguyen AB; Lee P; Port JL; Altorki NK
Eur J Cardiothorac Surg; 2017 Mar; 51(3):511-517. PubMed ID: 28007869
[TBL] [Abstract][Full Text] [Related]
13. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
[TBL] [Abstract][Full Text] [Related]
14. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
Abughararah TZ; Jeong YH; Alabbood F; Chong Y; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2021 Apr; 59(4):783-790. PubMed ID: 33150427
[TBL] [Abstract][Full Text] [Related]
15. Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study.
Zhai W; Duan F; Zheng Y; Yan Q; Dai S; Chen T; Chen J; Wang J
World J Surg Oncol; 2020 Sep; 18(1):258. PubMed ID: 32998771
[TBL] [Abstract][Full Text] [Related]
16. [Advances in Lymph Node Metastasis and the Modes of Lymph Node
Dissection in Early Stage Non-small Cell Lung Caner].
Ding N; Mao Y
Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):359-63. PubMed ID: 27335297
[TBL] [Abstract][Full Text] [Related]
17. Results of video-assisted thoracic surgery versus thoracotomy in surgical resection of pN2 non-small cell lung cancer in a Chinese high-volume Center.
Liu C; Guo C; Gan F; Mei J; Pu Q; Liu Z; Zhu Y; Liao H; Ma L; Lin F; Liu L
Surg Endosc; 2021 May; 35(5):2186-2197. PubMed ID: 32394172
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.
Wu Yl; Huang ZF; Wang SY; Yang XN; Ou W
Lung Cancer; 2002 Apr; 36(1):1-6. PubMed ID: 11891025
[TBL] [Abstract][Full Text] [Related]
20. Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.
Deng HY; Li D; Qiu XM; Zhu DX; Tang X; Zhou Q
ANZ J Surg; 2021 Nov; 91(11):E696-E702. PubMed ID: 34405519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
